(Q44612726)

4 December 2017

title

Relapse or progression after hematopoietic cell transplantation using nonmyeloablative conditioning: effect of interventions on outcome (English)

1 reference

transplantation conditioning

4 December 2017

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550814

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00225-X

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00225-X

20 March 2024

8

Rainer Storb

1 reference

4 December 2017

9

Brenda M Sandmaier

1 reference

4 December 2017

2

Barry E Storer

1 reference

4 December 2017

6

Thomas R Chauncey

1 reference

4 December 2017

5

David G Maloney

1 reference

4 December 2017

7

Ann E Woolfrey

1 reference

4 December 2017

4

Mary E D Flowers

1 reference

4 December 2017

Wolfgang A. Bethge

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550814

20 March 2024

Michael B. Maris

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550814

20 March 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14550814

20 March 2024

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

http://www.exphem.org/article/S0301472X0300225X/pdf

file format

Portable Document Format

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14550814

https://api.elsevier.com/content/article/PII:S0301472X0300225X?httpAccept=text/xml

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00225-X

https://api.elsevier.com/content/article/PII:S0301472X0300225X?httpAccept=text/plain

20 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00225-X

20 March 2024

published in

Experimental Hematology

1 reference

4 December 2017

volume

31

1 reference

4 December 2017

issue

10

1 reference

4 December 2017

page(s)

974-980

1 reference

Antileukemic effects of rapid cyclosporin withdrawal in patients with relapsed chronic myeloid leukemia after allogeneic bone marrow transplantation

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Relapse of acute leukemia after marrow transplantation: natural history and results of subsequent therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Second allogeneic marrow transplantation for patients with recurrent leukemia after initial transplant with total-body irradiation-containing regimens

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Adoptive immunotherapy for relapse of chronic myeloid leukemia after allogeneic bone marrow transplant: equal efficacy of lymphocytes from sibling and matched unrelated donors

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Donor leukocyte infusions in 140 patients with relapsed malignancy after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Donor lymphocyte infusions for relapsed multiple myeloma after allogeneic stem-cell transplantation: predictive factors for response and long-term outcome

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Successful allogeneic stem-cell transplantation with prophylactic stepwise G-CSF primed-DLIs for relapse after autologous transplantation in mantle cell lymphoma: a case report and literature review on the evidence of GVL effects in MCL.

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Non-myeloablative allografting from human leucocyte antigen-identical sibling donors for treatment of acute myeloid leukaemia in first complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induc

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Donor lymphocyte infusions mediate superior graft-versus-leukemia effects in mixed compared to fully allogeneic chimeras: a critical role for host antigen-presenting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

An EBMT registry matched study of allogeneic stem cell transplants for lymphoma: allogeneic transplantation is associated with a lower relapse rate but a higher procedure-related mortality rate than autologous transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Haematopoietic stem cell transplantation for patients with myelo-dysplastic syndromes and secondary acute myeloid leukaemias: a report on behalf of the Chronic Leukaemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT)

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Second allogeneic transplantation after failure of first autologous transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Allografting after nonmyeloablative conditioning as a treatment after a failed conventional hematopoietic cell transplant

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Donor lymphocyte infusions to treat hematologic malignancies in relapse after allogeneic blood or marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

The toxicity and efficacy of donor lymphocyte infusions given after reduced-intensity conditioning allogeneic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Induction of graft-versus-host disease as immunotherapy for relapsed chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0301-472X%2803%2900225-X

7 January 2021

Prospective trial of chemotherapy and donor leukocyte infusions for relapse of advanced myeloid malignancies after allogeneic stem-cell transplantation

10

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00225-X

Allogeneic bone marrow transplantation for secondary leukemia or myelodysplasia

20 March 2024

22

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00225-X

HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative conditioning for patients with hematologic malignancies

20 March 2024

24

1 reference

https://api.crossref.org/works/10.1016/S0301-472X(03)00225-X

20 March 2024

Identifiers

1 reference

4 December 2017

1 reference